Geron files $250 million shelf registration

By Laura Lutz

Des Moines, Aug. 4 - Geron Corp. filed a $250 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The filing covers debt securities, common stock, preferred stock and warrants. The securities may be structured as convertibles.

The proceeds will be used for general corporate purposes.

Geron is a Menlo Park, Calif.-based biopharmaceutical company that is developing treatments for cancer and degenerative diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.